Literature DB >> 17116698

Long-term cognitive and motor deficits after enterovirus 71 brainstem encephalitis in children.

Mei-Chih Huang1, Shih-Min Wang, Yung-Wen Hsu, Hui-Chen Lin, Chia-Yu Chi, Ching-Chuan Liu.   

Abstract

OBJECTIVES: Several large outbreaks of enterovirus 71 infections have occurred in Taiwan during the past decade. Brainstem encephalitis was the most common neurologic complication. This study was designed to determine the long-term cognitive and motor outcomes of children with enterovirus 71 brainstem encephalitis.
METHODS: We conducted a prospective follow-up study of children who met the case definition for enterovirus 71 brainstem encephalitis. Subjects were stratified into isolated brainstem encephalitis (stage II), autonomic nervous system dysregulation (stage IIIa), and pulmonary edema (stage IIIb). The subjects and their parents or guardians were interviewed using structured questionnaires and received comprehensive cognitive and neurologic examinations. Motor coordination, visual-motor skill, and intellectual ability were evaluated.
RESULTS: Follow-up studies were conducted in 63 previously healthy children with enterovirus 71 brainstem encephalitis (49 stage II, 7 stage IIIa, and 7 stage IIIb). The mean time to follow-up was 2.8 +/- 1.0 years (range: 1.4-4.9 years). Boys outnumbered girls by 3 to 2. The mean age at diagnosis was 2.4 +/- 1.4 years (range: 0.3-7.1 years). The most common abnormal neurologic findings on admission were altered consciousness (47.6%), followed by abnormal activities of daily living (52.4%), cerebellar dysfunction (17.5%), and cranial nerve palsy (15.9%). At follow-up, 51 of 63 children had no detectable deficits. Among the remaining 12 children, 3 died during the follow-up. The remaining 9 children (14.3%) had residual deficits. Two of these with stage IIIb disease continued to have severe motor and respiratory failure.
CONCLUSIONS: Residual defects were still present in a significant proportion of children with enterovirus 71 brainstem encephalitis at >2 years after their hospitalization. Children with stage II disease were most likely to have residual cerebellar defects. Those with stage IIIb disease continued to have severe respiratory and motor impairment. Long-term follow-up of this cohort is needed to determine the ultimate prognosis.

Entities:  

Mesh:

Year:  2006        PMID: 17116698     DOI: 10.1542/peds.2006-1547

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  37 in total

Review 1.  Is a multivalent hand, foot, and mouth disease vaccine feasible?

Authors:  Michel Klein; Pele Chong
Journal:  Hum Vaccin Immunother       Date:  2015-05-26       Impact factor: 3.452

2.  Reemerging of enterovirus 71 in Taiwan: the age impact on disease severity.

Authors:  S-M Wang; T-S Ho; H-C Lin; H-Y Lei; J-R Wang; C-C Liu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-09       Impact factor: 3.267

3.  Immunodeficient mouse models with different disease profiles by in vivo infection with the same clinical isolate of enterovirus 71.

Authors:  Chun-Che Liao; An-Ting Liou; Ya-Shu Chang; Szu-Yao Wu; Chih-Shin Chang; Chien-Kuo Lee; John T Kung; Pang-Hsien Tu; Ya-Yen Yu; Chi-Yung Lin; Jen-Shiou Lin; Chiaho Shih
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

Review 4.  Hand, foot and mouth disease: current knowledge on clinical manifestations, epidemiology, aetiology and prevention.

Authors:  Susanna Esposito; Nicola Principi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-02-06       Impact factor: 3.267

5.  The Pathogenesis and Prevention of Encephalitis due to Human Enterovirus 71.

Authors:  Emily Jane Bek; Peter Charles McMinn
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

6.  Central nervous system (CNS) enterovirus infections: A single center retrospective study on clinical features, diagnostic studies, and outcome.

Authors:  Sarah D Torres; Dan Tong Jia; Emily M Schorr; Brian L Park; Alexandra Boubour; Amelia Boehme; Jyoti V Ankam; Jacqueline S Gofshteyn; Charles Tyshkov; Daniel A Green; Wendy Vargas; Jason Zucker; Anusha K Yeshokumar; Kiran T Thakur
Journal:  J Neurovirol       Date:  2019-09-16       Impact factor: 2.643

7.  Extracorporeal life support for treatment of children with enterovirus 71 infection-related cardiopulmonary failure.

Authors:  Sheng-Ling Jan; Shing-Jong Lin; Yun-Ching Fu; Ching-Shiang Chi; Chung-Chi Wang; Hao-Ji Wei; Yen Chang; Betau Hwang; Po-Yen Chen; Fang-Liang Huang; Ming-Chih Lin
Journal:  Intensive Care Med       Date:  2009-12-24       Impact factor: 17.440

8.  Response of Severe EV71-Infected Patients to Hyperimmune Plasma Treatment: A Pilot Study.

Authors:  Chonnamet Techasaensiri; Artit Wongsa; Thanyawee Puthanakit; Kulkanya Chokephaibulkit; Tawee Chotpitayasunondh; Ubonwon Charoonruangrit; Somjai Sombatnimitsakul; Pilaipan Puthavathana; Hatairat Lerdsamran; Prasert Auewarakul; Boonrat Tassaneetrithep
Journal:  Pathogens       Date:  2021-05-19

9.  The burden of hand, foot, and mouth disease among children under different vaccination scenarios in China: a dynamic modelling study.

Authors:  Zhixi Liu; Jie Tian; Yue Wang; Yixuan Li; Jing Liu-Helmersson; Sharmistha Mishra; Abram L Wagner; Yihan Lu; Weibing Wang
Journal:  BMC Infect Dis       Date:  2021-07-05       Impact factor: 3.090

10.  First evidence of enterovirus A71 and echovirus 30 in Uruguay and genetic relationship with strains circulating in the South American region.

Authors:  Andrés Lizasoain; Daiana Mir; Matías Salvo; Viviana Bortagaray; Gisela Masachessi; Adrián Farías; Nélida Rodríguez-Osorio; Silvia Nates; Matías Victoria; Rodney Colina
Journal:  PLoS One       Date:  2021-08-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.